Ratings changes for Eos Energy Enterprises, Coinbase Global, NetApp, Fortinet, Axon Enterprise, TG Therapeutics, Wingstop and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.

July 13th, 2026

I endorsed someone else's model for the first time (Ad)

Porter Stansberry spent 30 years ignoring outside investment systems - until he met Emmet Savage in Dublin. Savage's model, built on Hamiltonian mechanics applied to equity analysis, has delivered nearly 2,000% returns over 17 years with only one losing year.
What convinced Porter wasn't the returns. It was the sell discipline - a framework that identifies the exact moment a position's energy begins to decay, signaling an exit before the decline. He calls it the most rigorous sell system he has ever seen, comparing its edge to RenTech's famed Medallion Fund.

Watch Porter's full breakdown of Project Prophet and Emmet's system

Today's Top Stories

AMD's 5C Deal Positions It as a Direct NVIDIA Rival

By Thomas Hughes | July 13, 2026 09:20 AM

7 Stocks to Watch Before AI Headlines Peak (Ad)

By StockEarnings

AST SpaceMobile’s Next Launches Could Decide Whether Its Rally Regains Orbit

By Jessica Mitacek | July 13, 2026 08:45 AM

3 Overlooked Stocks Positioned for the Next Market Rotation

By Bridget Bennett | July 13, 2026 07:35 AM

July 16 Will Change Nvidia Forever (Ad)

By TradeSmith

3 Non-Tech Stocks Still Winning Big on AI

By Nathan Reiff | July 13, 2026 07:00 AM

Power Struggle: Wolfspeed Sues Navitas Over AI Chips

By Jeffrey Neal Johnson | July 11, 2026 08:40 AM

Quick Links

Analyst Ratings My MarketBeat Account Settings MarketBeat All Access Stock Lists Stock Screener Calculators Premium Reports Best Stocks to Buy in July

He bet half his $9 billion on ONE stock (Ad)

One of the most successful fund managers of the past 50 years put more than half of his $9 billion portfolio - roughly $4.5 billion - into a single little-known company. Then his firm bought more shares for 61 straight trading days.
The former CEO of Google followed with a nine-figure partnership. The White House invoked emergency powers to protect what this company controls. A July 13th deadline could trigger a flood of institutional buying. Whitney Tilson, who called Netflix at 78 cents and Apple at 38 cents, is giving away the name and ticker free.

Watch the free presentation and get the ticker before July 13th

Analysts' Upgrades

American Express (NYSE:AXP) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $400.00 price target on the stock, up from $328.00. This represents a 12.4% upside from the current price of $355.79.

Biogen (NASDAQ:BIIB) was upgraded by Truist Financial Corporation from "hold" to "buy". They now have a $235.00 price target on the stock, up from $190.00. This represents a 16.5% upside from the current price of $201.66.

Casey's General Stores (NASDAQ:CASY) was upgraded by Northcoast Research from "neutral" to "buy". They now have a $950.00 price target on the stock. This represents a 12.1% upside from the current price of $847.75.

Saia (NASDAQ:SAIA) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $502.00 price target on the stock, up from $499.00. This represents a 16.3% upside from the current price of $431.83.

Verra Mobility (NASDAQ:VRRM) was upgraded by JPMorgan Chase & Co. from "underweight" to "neutral". They now have a $6.00 price target on the stock, up from $5.00. This represents a 30.0% upside from the current price of $4.62.

View More Upgrades

Fewer coins. More demand. One result. (Ad)

There's a coin trading under $1 right now where two forces are about to collide.
On one side, demand is set to climb. The largest bank in the country is building real blockchain infrastructure… production-level, not a pilot… on this specific network, designed to carry serious institutional volume as it goes live this year.
On the other side, supply is tightening. New issuance has slowed, and ongoing network usage steadily pulls coins out of circulation. The more the network gets used, the fewer coins remain.

Get my #1 coin before this window closes.

A $22.7 billion backlog, 49% revenue growth, and zero debt (Ad)

One company grew Q1 revenue 49% year over year with a 43% gross margin and zero debt. Another holds a $22.7 billion backlog, $2 billion in cash, and more than doubled adjusted EBITDA to $78 million. A semiconductor-test leader saw revenue climb from $686M to $1.282B while analysts model 82.9% EPS growth for 2026.
A free report names all seven companies, breaks down each balance sheet and growth profile, and flags which are expensive, which charts look broken, and where execution risk sits.

Click here to get your free copy of this report today

Analysts' New Coverage

Alkermes (NASDAQ:ALKS) is now covered by JPMorgan Chase & Co.. They set a "neutral" rating and a $60.00 price target on the stock. This represents a 17.2% upside from the current price of $51.18.

Apyx Medical (NASDAQ:APYX) is now covered by HC Wainwright. They set a "buy" rating and a $7.00 price target on the stock. This represents a 60.4% upside from the current price of $4.37.

BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by JPMorgan Chase & Co.. They set a "neutral" rating and a $12.00 price target on the stock. This represents a 19.8% upside from the current price of $10.02.

Candel Therapeutics (NASDAQ:CADL) is now covered by Stifel Nicolaus. They set a "buy" rating and a $22.00 price target on the stock. This represents a 130.1% upside from the current price of $9.56.

Capstone Energy+ (NASDAQ:CEPL) is now covered by BWS Financial. They set a "buy" rating and a $20.00 price target on the stock. This represents a 86.0% upside from the current price of $10.75.

Denali Therapeutics (NASDAQ:DNLI) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $29.00 price target on the stock. This represents a 13.1% upside from the current price of $25.65.

First Carolina Financial Services (NYSE:FCBM) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $15.00 price target on the stock. This represents a 16.2% upside from the current price of $12.91.

Glass House Brands (NYSE:GLAS) is now covered by Lake Street Capital. They set a "buy" rating and a $17.00 price target on the stock. This represents a 47.2% upside from the current price of $11.55.

Honeywell Aerospace (NASDAQ:HONA) is now covered by Evercore Inc. They set an "in-line" rating and a $250.00 price target on the stock. This represents a 16.6% upside from the current price of $214.40.

Kardigan (NASDAQ:KARD) is now covered by Leerink Partners. They set an "outperform" rating and a $37.00 price target on the stock. This represents a 60.7% upside from the current price of $23.02.

Kardigan (NASDAQ:KARD) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $51.00 price target on the stock. This represents a 121.5% upside from the current price of $23.02.

Legend Biotech (NASDAQ:LEGN) is now covered by JPMorgan Chase & Co.. They set a "neutral" rating and a $35.00 price target on the stock. This represents a 35.7% upside from the current price of $25.80.

Liftoff Mobile (NASDAQ:LFTO) is now covered by Tigress Financial. They set a "buy" rating and a $39.00 price target on the stock. This represents a 59.6% upside from the current price of $24.44.

NervGen Pharma (NASDAQ:NGEN) is now covered by Leerink Partners. They set an "outperform" rating and a $10.00 price target on the stock. This represents a 402.0% upside from the current price of $1.99.

NLS Pharmaceutics (NASDAQ:NCEL) is now covered by Laidlaw. They set a "buy" rating and a $23.00 price target on the stock. This represents a 459.6% upside from the current price of $4.11.

NovoCure (NASDAQ:NVCR) is now covered by JPMorgan Chase & Co.. They set a "neutral" rating and a $17.00 price target on the stock. This represents a 5.4% upside from the current price of $16.13.

Park Aerospace (NYSE:PKE) is now covered by Needham & Company LLC. They set a "buy" rating and a $43.00 price target on the stock. This represents a 22.6% upside from the current price of $35.08.

Spruce Biosciences (NASDAQ:SPRB) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $160.00 price target on the stock. This represents a 223.6% upside from the current price of $49.45.

Walt Disney (NYSE:DIS) is now covered by Benchmark Co.. They set a "buy" rating and a $115.00 price target on the stock. This represents a 18.5% upside from the current price of $97.08.

West Pharmaceutical Services (NYSE:WST) is now covered by BNP Paribas Exane. They set an "outperform" rating and a $447.00 price target on the stock. This represents a 25.1% upside from the current price of $357.19.

Whirlpool (NYSE:WHR) is now covered by BNP Paribas Exane. They set a "neutral" rating and a $43.00 price target on the stock. This represents a 6.9% upside from the current price of $40.23.

Whitehawk Therapeutics (NASDAQ:WHWK) is now covered by Leerink Partners. They set an "outperform" rating and a $9.00 price target on the stock. This represents a 125.6% upside from the current price of $3.99.

York Space Systems (NYSE:YSS) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $32.00 price target on the stock. This represents a 64.7% upside from the current price of $19.42.

View More New Coverage

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial